Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for prolonged severe migraine attack
2005-004810-34Phase 4Terminated
- Sponsor
- Ville Artto
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine with aura and migraine without aura comparing Hydrocortisone with Placebo (2 arms). Primary endpoints: Proportion completely pain-free after infusion and Time to significant pain relief from start of infusion. Started Oct 2005; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
migraine with auramigraine without aura
Beyond the preview
Go deeper on 2005-004810-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004810-34.